Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Tactile ... included in the medical records. The requirement of a basic pump trial even ...

Tactile Systems Technology, Inc., a medical technology company ... of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides ...

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and ...

MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology ...

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and ...

Tactile Systems (TCMD ... throughout the United States for the treatment of both upper and lower extremity lymphedema. Nimbl’s expanded availability to include lower extremity conditions ...

For 2025, Tactile Systems projects revenue growth of 8-10%, with expectations of $316-$322 million. The company is focusing on expanding its lymphedema and airway clearance product lines and ...